Jane Street Group, LLC Nrx Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.29 - $0.7 $8,028 - $19,379
27,685 New
27,685 $13,000
Q2 2023

Aug 14, 2023
BUY
$0.46 - $0.89 $6,923 - $13,396
15,052 New
15,052 $7,000
Q1 2022

May 17, 2022
SELL
$2.45 - $5.04 $131,643 - $270,809
-53,732 Closed
0 $0
Q4 2021

Feb 15, 2022
SELL
$4.5 - $11.91 $104,850 - $277,503
-23,300 Reduced 30.25%
53,732 $257,000
Q3 2021

Nov 16, 2021
BUY
$8.52 - $24.77 $656,312 - $1.91 Million
77,032 New
77,032 $714,000

Others Institutions Holding NRXP

# of Institutions
2
Shares Held
17.4K
Call Options Held
0
Put Options Held
0
View Full List

About NRX Pharmaceuticals, Inc.

NRXP Quotes by TradingView
  • Ticker NRXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,641,296
  • Market Cap $111M
  • Description
  • NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...
More about NRXP
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email